Illustration by Moukkaa

Company Information

As of 10/10/2022
Country
U.S.
Headquarters
Parsippany, N.J.
Industry
Pharmaceuticals
CEO
Kristin Peck
Company Type
Public
Ticker
ZTS
Revenues ($M)
$7,776
Profits ($M)
$2,035
Market Value ($M)
$69,420
Employees
12,100
Market value as of Sept. 30, 2022.

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$7,776
16.5%
Profits ($M)
$2,037
24.4%
Assets ($M)
$13,900
-
Total Stockholder Equity ($M)
$4,543
-

Profit Ratios

Profit as % of Revenues
26.2%
Profits as % of Assets
14.7%
Profits as % of Stockholder Equity
44.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
427
EPS % Change (from 2020)
24.9%
EPS % Change (5 year annual rate)
20.9%
EPS % Change (10 year annual rate)
-

Total Return

Total Return to Investors (2021)
48.2%
Total Return to Investors (5 year, annualized)
36.2%
Total Return to Investors (10 year, annualized)
-

Zoetis Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$6,6756.6%$1,6389.2%$13,609$3,769
2020$6,2607.5%$1,5005%$11,545$2,708
2019$5,8259.8%$1,42865.3%$10,777$2,185
2018$5,3078.6%$8645.2%$8,586$1,770
2017$4,8882.6%$821142.2%$7,649$1,487
SHOW MORE
FortuneDataStore ad
Lists ranking Zoetis
RANK440
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
RANK20
Change the World - 2022...READ MORE